Contact
QR code for the current URL

Press release Box-ID: 287971

PULSION Medical Systems SE Hans-Riedl-Str. 21 85622 Feldkirchen, Germany https://www.pulsion.com/
Contact Ms Silvia Klaus +49 89 459914102
Company logo of PULSION Medical Systems SE
PULSION Medical Systems SE

Ex-CEO and major shareholder Dr. Burkhard Wittek sues PULSION for continuation of salary payments due to alleged unlawful dismissal

Initial value of the claim: EUR 617,760

(PresseBox) ( München, )
Former CEO Dr. Burkhard Wittek, who retired from the Board of PULSION Medical Systems AG after just six months of service, has applied to the courts for a judicial finding against the company that the cancellation of his earlier Board of Management contract was not legally effective.

The initial value of the claim of EUR 617,760 has meanwhile been reduced to EUR 128,700 by the responsible district court München I. The period of notice agreed with former CEO Dr. Burkhard Wittek was one month. The company defends itself against the claim, in particular as it wishes to avoid payments lacking legal grounds to a major shareholder at the expense of the other shareholders. A date for the hearing has not yet been announced.

PULSION Medical Systems SE

PULSION Medical Systems AG, founded in 1990, has become one of the leading specialists for intelligent medical diagnosis and therapy management systems and has been listed on the Stock Exchange in Frankfurt since 2001. The repeated development of innovative product lines in the medtech field is the basis for creation and expansion of the attractive disposable business with sterile products and pharmaceuticals.

The business unit PULSION Intensive Care covering intensive care medicine, perioperative medicine and emergency medicine focuses on the management of cardiovascular and organ functions of critically ill patients.

Products and activities of the business unit PULSION Pharma are directed at the diagnosis and therapy management of organ and tissue perfusion in ophthalmology, surgery and hepatology.

PULSION products are marketed worldwide via own sales channels or secondary distribution. All products are certified with the CE mark which is basis for marketing in the EU and some other countries. The US-American FDA approval and the Japanese market approval have been issued for selected product lines.

Further information about PULSION is available at www.pulsion.com.

The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.
Important note:

Systematic data storage as well as the use of even parts of this database are only permitted with the written consent of unn | UNITED NEWS NETWORK GmbH.

unn | UNITED NEWS NETWORK GmbH 2002–2022, All rights reserved

The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.